Position in AMGN
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$3,013,200
+$261,382 QoQ
Shares Held
8,321
+6.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,080
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glenview Trust Co holds $465,808,551 across 12 Drug Manufacturers - General names. AMGN ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
188,484 | $226,073,382 | |
| 2 | ABBV |
AbbVie Inc.
|
422,207 | $106,244,168 | |
| 3 | MRK |
Merck & Co., Inc.
|
381,609 | $49,036,756 | |
| 4 | JNJ |
Johnson & Johnson
|
150,964 | $38,340,326 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
195,795 | $24,736,739 | |
| 6 | PFE |
Pfizer Inc
|
442,787 | $10,662,310 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
102,223 | $5,890,089 | |
| 8 | AMGN |
Amgen Inc
This page
|
8,321 | $3,013,200 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,013,200 | 8,321 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $2,751,818 | 7,821 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,571,673 | 7,857 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,373,583 | 8,411 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,365,466 | 8,472 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,656,897 | 8,528 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $2,257,923 | 8,663 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,022,328 | 9,380 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,946,090 | 9,429 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,728,618 | 9,597 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,733,885 | 9,492 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,464,260 | 9,169 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,053,018 | 9,247 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,200,166 | 9,101 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,361,395 | 8,991 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,077,962 | 9,219 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,228,871 | 9,161 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,052,325 | 8,487 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,684,575 | 7,488 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,650,801 | 7,763 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,969,987 | 8,082 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,995,953 | 8,022 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,603,692 | 6,975 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,785,474 | 7,025 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,659,039 | 7,034 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,462,494 | 7,214 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||